2021 NOSCM | Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Mohamed Kharfan-Dabaja, MD
Date of Release
May 14th, 2025
